Jubilant Pharmova's USFDA nod for Spokane facility's Line 3

Jubilant Pharmova Limited announced that its subsidiary, Jubilant HollisterStier LLC (JHS), has received USFDA approval for commercial batch manufacturing on Line 3 of its contract manufacturing facility in Spokane, USA. This new Isolator-based fill and finish line will be used for the first product's commercial production. JHS is a key contract manufacturer of sterile injectables and ophthalmics, serving the pharmaceutical and biopharmaceutical industries. This approval signifies an expansion of JHS's capabilities and its role in supplying regulated markets.